Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

Gilead teams up with WHO again to eliminate parasitic tropical disease

Gilead will donate vials of its antifungal medication AmBisome to help global efforts in eliminating visceral leishmaniasis.

Latest news

European STI cases reach record high amid testing and prevention gaps

Cases of syphilis and gonorrhoea have tripled and quadrupled, respectively, since 2015 – highlighting the need for sound treatment and prevention methods.

Concept Life Sciences and OpenBench partner on drug discovery services

The partnership will combine OpenBench’s discovery platform with Concept Life Sciences’ expertise in medicinal chemistry.

Gilead Sciences completes Tubulis acquisition for $5bn

Gilead acquired all outstanding equity of Tubulis for $3.15bn upfront, plus up to $1.85bn in milestone payments.

Eli Lilly maintains M&A streak with $202m Engage Bio buyout

Lilly’s takeover of Engage Bio marks the seventh acquisition for the big pharma since the start of 2026.

Podcast: Supply chains, obesity drugs, and patents dominate Q1 earnings trends

The healthcare team covers Q1 results from pharma and medtech companies and provides a wrap-up of the key takeaways.